SOLVENTUM CORPORATION (SOLV) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $2.00M; Additional Paid in CapitalUSD $3.92B; Treasury Stock, Common, ValueUSD $355.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-669.00M.
- 2026-03-31: Common Stock, Value, IssuedUSD $2.00M; Additional Paid in CapitalUSD $3.90B; Treasury Stock, Common, ValueUSD $67.00M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-670.00M.
- 2025-12-31: Common Stock, Value, IssuedUSD $2.00M; Additional Paid in CapitalUSD $3.88B; Treasury Stock, Common, ValueUSD $0.00; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-625.00M.
- 2025-09-30: Common Stock, Value, IssuedUSD $2.00M; Additional Paid in CapitalUSD $3.85B; Treasury Stock, Common, ValueUSD (m); Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-604.00M.
SOLVENTUM CORPORATION Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Treasury Stock, Value, Acquired, Cost Method USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Shares, Acquired shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.00M | $3.92B | $355.00M | $-669.00M | $1.90B | $4.80B | 4.78M | 3 month · $288.00M 6 month · $355.00M | 3 month · $36.00M 6 month · $85.00M | (m) |
| 2026-03-31 | $2.00M | $3.90B | $67.00M | $-670.00M | $1.81B | $4.97B | 922.64K | 3 month · $67.00M | 3 month · $49.00M | 3 month · 922.64K |
| 2025-12-31 | $2.00M | $3.88B | $0.00 | $-625.00M | $1.80B | $5.05B | 0.00 | (m) | 12 month · $161.00M | 12 month · 0.00 |
| 2025-09-30 | $2.00M | $3.85B | (m) | $-604.00M | $1.73B | $4.99B | (m) | (m) | 3 month · $41.00M 9 month · $124.00M | (m) |
| 2025-06-30 | $2.00M | $3.81B | (m) | $-631.00M | $468.00M | $3.65B | (m) | (m) | 3 month · $34.00M 6 month · $83.00M | (m) |
| 2025-03-31 | $2.00M | $3.78B | (m) | $-899.00M | $378.00M | $3.26B | (m) | (m) | 3 month · $49.00M | (m) |
| 2024-12-31 | $2.00M | $3.77B | (m) | $-1.06B | $242.00M | $2.96B | (m) | (m) | 12 month · $108.00M | (m) |
| 2024-09-30 | $2.00M | $3.74B | (m) | $-765.00M | $211.00M | $3.19B | (m) | (m) | 3 month · $27.00M 9 month · $83.00M | (m) |
| 2024-06-30 | $2.00M | $3.72B | (m) | $-943.00M | $89.00M | $2.87B | (m) | (m) | 3 month · $46.00M 6 month · $52.00M | (m) |
| 2024-03-31 | (m) | (m) | (m) | $-958.00M | (m) | $3.85B | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $0.00 | (m) | $-337.00M | $0.00 | $11.67B | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | $11.58B | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | (m) | $11.73B | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | $11.67B | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | $11.74B | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | $12.06B | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |